EMVC — EMV Capital Share News
0.000.00%
- £10.55m
- £11.11m
- £1.45m
- 16
- 32
- 25
- 12
REG - EMV Capital PLC - TR-1
AnnouncementREG - EMV Capital PLC - PDS: Q4 Results and Clinical Programs Update
AnnouncementREG - EMV Capital PLC - PDS: VERSATILE-003 Phase 3 Clinical Trial
AnnouncementREG - EMV Capital PLC - PDS: up to $22mn Registered Direct Offering
AnnouncementREG - EMV Capital PLC - PDS Biotech reaffirms guidance for clinical trial
AnnouncementREG - EMV Capital PLC - ProAxsis: Status Update and Proposed Fundraise
AnnouncementREG - EMV Capital PLC - TR-1
AnnouncementREG - EMV Capital PLC - Grant of Share Options
AnnouncementREG - EMV Capital PLC - Q-Bot Fundraising
AnnouncementREG - EMV Capital PLC - TR-1
AnnouncementREG - EMV Capital PLC - Wanda Health Fundraising
AnnouncementREG - EMV Capital PLC - Close of Fundraising and Result of Retail Offer
AnnouncementREG - EMV Capital PLC - Result of Subscription
AnnouncementREG - EMV Capital PLC - WRAP Retail Offer
AnnouncementREG - EMV Capital PLC - Proposed Subscription and Retail Offer; Update
AnnouncementREG - EMV Capital PLC - PDS: Clinical Programs Update, 3rd Quarter Results
AnnouncementREG - EMV Capital PLC - Director/PDMR Shareholding
AnnouncementREG - EMV Capital PLC - Director/PDMR Shareholding
AnnouncementREG - EMV Capital PLC - PDS: 36-Month Overall Survival Rate announcement
Announcement